CEC INT'L HOLD(00759.HK)盈警:預計年度除税後虧損約2900萬至3100萬港元
格隆匯7月16日丨CEC INT'L HOLD(00759.HK)公吿,與截至2023年4月30日止年度的除税後溢利約49,600,000港元相比,公司預計截至2024年4月30日止年度將錄得除税後虧損約29,000,000港元至31,000,000港元。
本年度預期虧損主要歸因於以下四個主要原因:(1) 撤銷新冠疫情旅遊限制後,離境外遊人數顯著急升,導致零售銷售額減少;(2) 於本年度並無獲得來自香港政府的新冠疫情相關的補貼或資助(上一年度:18,832,000港元);(3) 投資物業公平價值虧損增加;及(4) 若干附屬公司的一次性重組開支。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.